An observational study in Arrhythmias, Cardiac, sponsored by Biotronik SE & Co. KG. Completed at 1 site in Hungary. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2011-11-16.
Sponsored by Biotronik SE & Co. KG · Observational
This investigation is designed to demonstrate the clinical efficacy and safety of the low-dose drug of the SIELLO leads in comparison to the non-steroid BPPU leads in a clinical investigation.
885 studies on the registry are indexed under Arrhythmias, Cardiac; 235 are open to participants now.
This study's enrollment of 88 is below the median of 200 across 414 observational studies indexed under Arrhythmias, Cardiac.
Browse Arrhythmias, Cardiac studies →Biotronik SE & Co. KG is the lead sponsor of 83 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with standard pacemaker indication who are refered to the hospital.
Exclusion Criteria:
Device: SIELLO JT/T · Device: Pacemaker therapy · Device: BPPU JT/T
Implantation of SIELLO and BPPU pacemaker leads
Also known as: BPPU JT/T
Pacemaker therapy
Implantation of SIELLO and BPPU pacemaker leads
This study is completed, as verified in Nov 2011. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Biotronik SE & Co. KG